drugset / Trial / NCT01960283

Methotrexate in the Treatment of Chronic Idiopathic Urticaria

NCT01960283 ↗

Phase 3 Completed 83 enrolled University Hospital, Tours
RandomizedParallel-groupDouble-blindTreatment

Summary

Chronic urticaria is defined by urticarial lesions persisting at 6 weeks. The cause is not found in about 75% of cases (chronic idiopathic urticaria). The gold standard treatment consists of anti-H1 molecules. In severe cases, refractory to anti-H1, few therapeutic alternatives exist. Methotrexate, which is not expensive and often prescribed by dermatologists, has been efficiently tried in an open study on severe chronic idiopathic urticaria, and also in few case reports.

Timeline

Start
2011-11
Primary completion
2016-03
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 0.25 mg/kg Oral

Indications